Research Center for Analytical Science, College of Chemistry, Nankai University,
94 Weijin Road, Tianjin 300071, China
Prof. Dingbin Liu received his B.S. in 2006 from Lanzhou University and his Ph.D. in 2012 from the National Center for Nanoscience and Technology, China (NCNST) under the direction of Prof. Xingyu Jiang. After a short postdoctoral training at Dr. Xiaoyuan Chen' lab at the National Institutes of Health (NIH) under the support of NRC NIH/NIST Joint Postdoctoral Associateship, he joined the College of Chemistry at Nankai University in 2014. He is also a principal investigator at the State Key Laboratory of Medicinal Chemical Biology and the Collaborative Innovation Center of Chemical Science and Engineering (Tianjin). Prof. Liu was elected as the member of the Thousand Youth Talent Plan of China and the Hundred Youth Academic Leader of Nankai University. Prof. Liu is an associate editor of the journal Nanotheranostics.
A universal strategy for one-pot synthesis of SERS tags2018 Nanoscale
High-Precision Profiling of Sialic Acid Expression in Cancer Cells and Tissues Using Background-Free SERS TagsAnalytical Chemistry, 2017
In Situ Hot-Spot Assembly as a General Strategy for Probing Single BiomoleculesAnalytical Chemistry, 2017
Building Electromagnetic Hot Spots in Living Cells via Target-Triggered Nanoparticle DimerizationACS nano, 2017.
Live-Cell Pyrophosphate Imaging by in Situ Hot-Spot GenerationAnalytical Chemistry, 2017
Our research group aims to create advanced bioanalytical tools for better understanding of complex biological and pathological events, which provide invaluable information for early diagnosis of disease, monitoring therapeutic responses, and guiding drug discovery. In particular, we are interested in using fundamental principles of chemistry, physics, and biology to 1) develop point-of-care (POC) platforms for rapid diagnosis and on-site assessment of diseases, 2) develop high-sensitivity multiplex assay for detecting ultratrace biomarkers of interest in biological samples, and 3) develop plasmonic bioimaging systems with high signal-to-noise ratios for in vivo diagnostics.[Read more...]